Detalhe da pesquisa
1.
Progression pattern and post-progression survival following atezolizumab and bevacizumab treatment in advanced hepatocellular carcinoma.
Liver Int
; 44(6): 1343-1350, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38436529
2.
RECAM-J 2023-Validation and development of the Japanese version of RECAM for the diagnosis of drug-induced liver injury.
Hepatol Res
; 2024 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38642343
3.
Association Between Immune-Related Adverse Events and Survival in Patients with Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab.
Oncologist
; 28(7): e526-e533, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37023703
4.
Cell-free and concentrated ascites reinfusion therapy versus large-volume paracentesis for the treatment of cirrhotic patients with refractory ascites: A multicenter prospective observational study.
Hepatol Res
; 53(3): 238-246, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36433862
5.
Significant association between HLA-B*35:01 and onset of drug-induced liver injury caused by Kampo medicines in Japanese patients.
Hepatol Res
; 53(5): 440-449, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36583370
6.
Clinical outcomes of antithrombin III-based therapy for patients with portal vein thrombosis: A retrospective, multicenter study.
Hepatol Res
; 53(1): 51-60, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36136893
7.
A prospective observational cohort study of lenvatinib as initial treatment in patients with BCLC-defined stage B hepatocellular carcinoma.
BMC Cancer
; 22(1): 517, 2022 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35525913
8.
The Risk of Cirrhosis and Its Complications Based on PNPLA3 rs738409 G Allele Frequency.
Dig Dis
; 40(5): 625-634, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34808618
9.
Frequency of null genotypes of glutathione S-transferase M1 and T1 in Japanese patients with drug-induced liver injury.
Hepatol Res
; 52(10): 882-887, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35834381
10.
Safety and efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma in early clinical practice: A multicenter analysis.
Hepatol Res
; 52(3): 269-280, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34761470
11.
Extracellular vesicles secreted by HBV-infected cells modulate HBV persistence in hydrodynamic HBV transfection mouse model.
J Biol Chem
; 295(35): 12449-12460, 2020 08 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32651230
12.
A Deactivation Factor of Fibrogenic Hepatic Stellate Cells Induces Regression of Liver Fibrosis in Mice.
Hepatology
; 71(4): 1437-1452, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31549421
13.
PD-L1 is induced on the hepatocyte surface via CKLF-like MARVEL transmembrane domain-containing protein 6 up-regulation by the anti-HBV drug Entecavir.
Int Immunol
; 32(8): 519-531, 2020 07 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32219331
14.
Clinicopathological Features of Autoimmune Hepatitis with IgG4-Positive Plasma Cell Infiltration.
Dig Dis
; 39(3): 225-233, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-32731217
15.
Impact of Anti-GPIIb/IIIa Antibody-Producing B Cells as a Predictor of the Response to Lusutrombopag in Thrombocytopenic Patients with Liver Disease.
Dig Dis
; 39(3): 234-242, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-32759604
16.
Case of hepatitis B virus reactivation after ibrutinib therapy in which the patient remained negative for hepatitis B surface antigens throughout the clinical course.
Hepatol Res
; 51(2): 239-244, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32978866
17.
Analysis of efficacy of lenvatinib treatment in highly advanced hepatocellular carcinoma with tumor thrombus in the main trunk of the portal vein or tumor with more than 50% liver occupation: A multicenter analysis.
Hepatol Res
; 51(2): 201-215, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33270323
18.
[A case of simultaneous multicentric cancer in the gallbladder duct and the common bile duct without pancreaticobiliary maljunction].
Nihon Shokakibyo Gakkai Zasshi
; 118(4): 366-373, 2021.
Artigo
em Japonês
| MEDLINE | ID: mdl-33840718
19.
Intention-to-treat assessment of glecaprevir + pibrentasvir combination therapy for patients with chronic hepatitis C in the real world.
Hepatol Res
; 49(12): 1365-1373, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31323165
20.
Analysis of 307 cases with drug-induced liver injury between 2010 and 2018 in Japan.
Hepatol Res
; 49(1): 105-110, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30565816